Innovation Pharmaceuticals and U.S. Regional Biocontainment Laboratory Nearing Completion of Brilacidin Anti-SARS-CoV-2 (COVID-19) In Vitro Testing
Stock Information for Innovation Pharmaceuticals Inc
Loading
Please wait while we load your information from QuoteMedia.